3 FEBRUARY 2011 NEW ZEALAND GAZETTE, No. 11

Under section 18 of the Act, a copy of every submission will be forwarded to the applicant for the applicant’s information.

The following address is:

(a) where submissions on this application are to be sent; and

(b) where requests for copies of the public information relating to the application can be sent; and

(c) where public information relating to the application can be viewed; and

(d) the director-general’s address for service:

ACVM Group, New Zealand Food Safety (Ministry of Agriculture and Forestry), Level 5, South Tower, 68–86 Jervois Quay, Wellington 6011. Postal Address: PO Box 2835, Wellington 6140.

The applicant’s address for service is:

DuPont NZ Limited, Central Park Corporate Centre, Level 2, Building 5, 666 Great South Road, Epsom, Auckland 1051. Postal Address: PO Box 12172, Penrose, Auckland 1642.

Dated at Wellington this 27th day of January 2011.

MAREE ZINZLEY, Senior Manager (Approvals Operations), Ministry of Agriculture and Forestry (New Zealand Food Safety) (acting under delegated authority).

go596

Notice of Application to Register a Trade Name Product (Notice No. 254)

Maree Zinzley, Senior Manager (Approvals Operations) of the Ministry of Agriculture and Forestry (MAF) (New Zealand Food Safety), acting under delegated authority from the Director-General of MAF, gives notice, under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“the Act”), that the following application has been made to register a trade name product under section 9(1) of the Act:

Trade Name: Q-Drench Mineralised Multi-Combination Drench for Sheep

Reference: A010445

Active Ingredients and Concentrations:

Contains:

• Levamisole Hydrochloride 40.0g/L
• Closantel 37.5g/L
• Albendazole 25.0g/L
• Abamectin 1.0g/L
• Iodine 1.0mg/mL
• Cobalt 0.2mg/mL
• Copper 2.1mg/mL
• Zinc 0.6mg/mL
• Selenium 0.5mg/mL

Formulation Type: Aqueous suspension

General Use Claims: For the treatment and control in sheep of susceptible gastrointestinal roundworms (including strains with single and dual resistance to macrocyclic lactones, benzimidazoles, levamisole or closantel, and strains of Haemonchus contortus with emerging resistance to closantel). Also effective against lungworm, tapeworms, mature and late immature liver fluke, nasal bot and itch mite. Contains copper, cobalt, zinc, iodine and selenium.

Any person may make a written submission to the director-general concerning this application.

Under sections 16 and 17 of the Act, a written submission:

(a) must state in full the reasons for making the submission; and

(b) may state any decision sought on that application; and

(c) must be received by the director-general no later than 30 working days after the date of notification in the New Zealand Gazette.

Under section 18 of the Act, a copy of every submission will be forwarded to the applicant for the applicant’s information.

The following address is:

(a) where submissions on this application are to be sent; and

(b) where requests for copies of the public information relating to the application can be sent; and

(c) where public information relating to the application can be viewed; and

(d) the director-general’s address for service:

ACVM Group, New Zealand Food Safety (Ministry of Agriculture and Forestry), Level 5, South Tower, 68–86 Jervois Quay, Wellington 6011. Postal Address: PO Box 2835, Wellington 6140.

The applicant’s address for service is:

Jurox NZ Limited, 8 Kordel Place, East Tamaki, Auckland, New Zealand. Australian Address: Jurox Pty Ltd, 85 Gardiner Road, Rutherford, New South Wales 2320, Australia.

Dated at Wellington this 27th day of January 2011.

MAREE ZINZLEY, Senior Manager (Approvals Operations), Ministry of Agriculture and Forestry (New Zealand Food Safety) (acting under delegated authority).

go597

Notice of Application to Register a Trade Name Product (Notice No. 255)

Maree Zinzley, Senior Manager (Approvals Operations) of the Ministry of Agriculture and Forestry (MAF) (New Zealand Food Safety), acting under delegated authority from the Director-General of MAF, gives notice, under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“the Act”), that the following application has been made to register a trade name product under section 9(1) of the Act:

Trade Name: Eclipse E Injection

Reference: A010640

Active Ingredients and Concentrations:

Contains:

• Eprinomectin 7g/L
• Levamisole phosphate 223g/L

Formulation Type: Solution

General Use Claim: Subcutaneous injection for the treatment and control of internal parasites in cattle.

Any person may make a written submission to the director-general concerning this application.

Under sections 16 and 17 of the Act, a written submission:

(a) must state in full the reasons for making the submission; and

(b) may state any decision sought on that application; and

(c) must be received by the director-general no later than 30 working days after the date of notification in the New Zealand Gazette.

Under section 18 of the Act, a copy of every submission will be forwarded to the applicant for the applicant’s information.